Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Curr Opin Nephrol Hypertens. 2011 May;20(3):218-23. doi: 10.1097/MNH.0b013e3283446193.
Estimated glomerular filtration rate (eGFR) reporting has been implemented by laboratories and jurisdictions around the world. The purpose of this review is to summarize the recent literature evaluating the association between eGFR reporting and outcomes, specifically assessing its impact on nephrology referrals and characteristics of the referred population.
Eight studies have evaluated the association between eGFR reporting and nephrology referrals, all published within the last 6 years. These studies consistently show an increase in referrals and referral rates following eGFR reporting. This increase in nephrology referrals was predominantly seen in women and the elderly. An increased referral rate and increased recognition of chronic kidney disease were noted amongst patients with stage 3 or higher kidney disease. Whether eGFR reporting results in an increase in 'inappropriate' referrals and increased resource use has been poorly studied.
Reporting of eGFR is associated with an increase in nephrology referrals, particularly among women and the elderly. Whether eGFR reporting is associated with improved patient outcomes remains to be determined.
估计肾小球滤过率(eGFR)报告已经在世界各地的实验室和司法管辖区实施。本综述的目的是总结最近评估 eGFR 报告与结局之间关联的文献,特别是评估其对肾脏病转诊和转诊人群特征的影响。
八项研究评估了 eGFR 报告与肾脏病转诊之间的关联,这些研究均在过去 6 年内发表。这些研究一致表明,eGFR 报告后转诊数量和转诊率增加。女性和老年人中肾脏病转诊的增加更为明显。在 3 期或更高阶段的肾脏病患者中,观察到转诊率增加和对慢性肾脏病的认识增加。eGFR 报告是否会导致“不适当”转诊和资源使用增加,研究甚少。
eGFR 报告与肾脏病转诊的增加相关,特别是在女性和老年人中。eGFR 报告是否与患者结局的改善相关仍有待确定。